SET domain protein lysine methyltransferases: Structure, specificity and catalysis

被引:0
|
作者
C. Qian
M. -M. Zhou
机构
[1] New York University,Department of Molecular Physiology and Biophysics, Mount Sinai School of Medicine
关键词
SET domain; histone lysine methylation; structure-function; chromatin modifications;
D O I
暂无
中图分类号
学科分类号
摘要
Site- and state-specific lysine methylation of histones is catalyzed by a family of proteins that contain the evolutionarily conserved SET domain and plays a fundamental role in epigenetic regulation of gene activation and silencing in all eukaryotes. The recently determined three-dimensional structures of the SET domains from chromosomal proteins reveal that the core SET domain structure contains a two-domain architecture, consisting of a conserved anti-parallel β-barrel and a structurally variable insert that surround a unusual knot-like structure that comprises the enzyme active site. These structures of the SET domains, either in the free state or when bound to cofactor S-adenosyl-L-homocysteine and/or histone peptide, mimicking an enzyme/cofactor/substrate complex, further yield the structural insights into the molecular basis of the substrate specificity, methylation multiplicity and the catalytic mechanism of histone lysine methylation.
引用
收藏
页码:2755 / 2763
页数:8
相关论文
共 50 条
  • [21] The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
    Bennett, Richard L.
    Swaroop, Alok
    Troche, Catalina
    Licht, Jonathan D.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (06):
  • [22] Preparation, Biochemical Analysis, and Structure Determination of SET Domain Histone Methyltransferases
    Bergamin, E.
    Couture, J. F.
    ENZYMES OF EPIGENETICS, PT A, 2016, 573 : 209 - 240
  • [23] Clinicopathologic significance of protein lysine methyltransferases in cancer
    Theodore Vougiouklakis
    Benjamin J. Bernard
    Nupur Nigam
    Kyunghee Burkitt
    Yusuke Nakamura
    Vassiliki Saloura
    Clinical Epigenetics, 2020, 12
  • [24] Clinicopathologic significance of protein lysine methyltransferases in cancer
    Vougiouklakis, Theodore
    Bernard, Benjamin J.
    Nigam, Nupur
    Burkitt, Kyunghee
    Nakamura, Yusuke
    Saloura, Vassiliki
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [25] Substrate and product specificities of SET domain methyltransferases
    Del Rizzo, Paul A.
    Trievel, Raymond C.
    EPIGENETICS, 2011, 6 (09) : 1059 - 1067
  • [26] Polypeptide substrate specificity of PsLSMT - A set domain protein methyltransferase
    Magnani, Roberta
    Nayak, Nihar R.
    Mazarei, Mitra
    Dirk, Lynnette M. A.
    Houtz, Robert L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) : 27857 - 27864
  • [27] SPECIFICITY OF THE HISTONE LYSINE METHYLTRANSFERASES FROM RAT-BRAIN CHROMATIN
    DUERRE, JA
    ONISK, DV
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 843 (1-2) : 58 - 67
  • [28] Kinetic manifestation of processivity during multiple methylations catalyzed by SET domain protein methyltransferases
    Dirk, Lynnette M. A.
    Flynn, E. Megan
    Dietzel, Kevin
    Couture, Jean-Francois
    Trievel, Raymond C.
    Houtz, Robert L.
    BIOCHEMISTRY, 2007, 46 (12) : 3905 - 3915
  • [29] SPECIFICITY OF THE HISTONE LYSINE METHYLTRANSFERASES FROM RAT-BRAIN CHROMATIN
    DUERRE, JA
    ONISK, DV
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1461 - 1461
  • [30] The Arabidopsis thaliana SET-domain-containing protein ASHH1/SDG26 interacts with itself and with distinct histone lysine methyltransferases
    María del Pilar Valencia-Morales
    José Alberto Camas-Reyes
    José Luis Cabrera-Ponce
    Raúl Alvarez-Venegas
    Journal of Plant Research, 2012, 125 : 679 - 692